IL17A and systemic lupus erythematosus: Abnormal cell subsets, such as CD4-CD8- double negative (DN) T cells and CD8+CD28- T cells have been identified in SLE patients and suggested be the main producers of IL-17 and IL-10, respectively [3,4,5].